Login / Signup

Real-world prescription of anti-COVID-19 drugs in hospitalized patients with COVID-19 in Japan.

Haruka ShidaMaki KomamineKazuhiro KajiyamaTakashi WakiHotaka MaruyamaYoshiaki Uyama
Published in: PloS one (2024)
This study revealed the real-world situation of anti-COVID-19 drug prescriptions in hospitalized COVID-19 patients in Japan. A prescribed drug would depend on the latest scientific evidence, such as efficacy, safety, and approval status, at the time of prescription. Understanding the prescription of anti-COVID-19 drugs will be important for providing the most up-to-date treatments to patients and evaluating the benefit and/or risk of anti-COVID-19 drugs based on the utilization of an electronic medical record database.
Keyphrases
  • sars cov
  • coronavirus disease
  • end stage renal disease
  • respiratory syndrome coronavirus
  • chronic kidney disease
  • ejection fraction
  • peritoneal dialysis
  • adverse drug
  • emergency department
  • electronic health record